Skip to main content

Table 2 Adverse events after PACAP38 infusion and treatment with ketorolac and sumatriptan

From: Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache

Variables

Pre-treatment (Ketorolac)

Pre-treatment (Sumatriptan)

Post-treatment (Ketorolac)

Post-treatment (Sumatriptan)

Palpitation

100%

94.1%

100%

100%

Flushing

100%

100%

100%

100%

Heat sensation

100%

100%

100%

100%

Nausea

0%

0%

0%

0%

Neck stiffness

11.8%

11.7%

17.7%

17.7%

Difficulty concentrating

5.9%

5.9%

23.5%

17.8%

Fatigue

23.5%

17.7%

23.5%

23.5%

Thirst

17.7%

11.8%

11.8%

23.5%

Facial puffiness

41.2%

35.3%

41.2%

17.7%